Era7 Bioinformatics expands to U.S., Opens office in Cambridge, Mass.

November 29, 2012

CAMBRIDGE, Mass. – Nov. 29, 2012 – Era7 Bioinformatics, a Next Generation Sequencing provider based in Spain, announced today the opening of its first U.S. office, located in the Cambridge  Innovation Center (CIC) in Cambridge, Massachusetts. Era7 expects to have three employees in  Cambridge by the end of 2013.

“When we first thought about expanding our company outside of Spain, we felt that the USA would be the first foreign market for us and that Massachusetts was the best option for our business,” said Era7  CEO, Eduardo Pareja. “Massachusetts will offer our company two important pieces: The most  innovative and advanced public and private research activities around genomics, biomedicine and biotechnology, and the best place to attract talented people to grow and extend our bacterial  genomics-based business.”

“Thanks to our growth strategy of investing in education, innovation and infrastructure, Massachusetts  continues to lead the world in life sciences,” said Governor Deval Patrick. “We welcome Era7  Bioinformatics to Massachusetts and look forward to their contributions to our thriving life sciences  community.”

“On behalf of the Center, I would like to extend our warmest congratulations to the team at Era7 as  they open their first U.S. office here in Massachusetts,” said Susan Windham-Bannister, Ph.D.,  President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing  Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. “The Commonwealth has emerged as a  stand-out leader in the field of bioinformatics, with a strong, technology-oriented workforce that will  provide a depth of talent for Era7 as they grow their business here.”

Era7 worked closely with the Massachusetts Life Sciences Center as they developed their plans for their first U.S. office.

“Congratulations to Eduardo and the Era7 team on the opening of their first U.S. office; it is an  achievement not just for the company, but for the Massachusetts supercluster, which continues to  grow as the U.S. base for international life sciences companies,” said Robert K. Coughlin, President &  CEO of MassBio, a biotechnology trade association representing 600+ member organizations. “We are excited to be a destination for innovative companies like Era7.”

More than one-half of all the genomic information available today, globally, comes from bacteria. Next  Generation Sequencing technologies have radically changed the scenario of genomic data acquisition  by means of lowering the sequencing prices by a factor of more than one-thousand over the past five  years. Era7’s BG7 bacterial genome annotation system was specially designed for Next Generation  Sequencing data for a bacterial genome. The open source BG7 system, which was successfully used  last year to obtain one of the first annotations of the E. coli German outbreak genome, was recently  published in the open access journal, PLOS ONE.

Founded in 2004, Era7 has become a leading company in Next Generation Sequencing and bacterial  genomics in Spain. Era7 is headquartered in Granada, with offices in Madrid, and currently employs 16 people, the majority of whom are researchers investigating new approaches for Genomics data  analysis based in Cloud Computing.

Era7’s new U.S. office is based at:
Era7 Bioinformatics
Cambridge Innovation Center
14th floor
Cambridge, MA 02142

About Era7 Bioinformatics
Era7 Bioinformatics is a Next Generation Sequencing service provider that specializes in Microbial genomics. Its business model is based on offering complete and integrated solutions, from project design to deep bioinformatics analysis and reporting. Era7 Bioinformatics is based in Research, Cloud Computing, Open Source and bacterial genomics specialization.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.